Meeting
2018 ASCO Annual Meeting
Comprehensive genomic characterization of urothelial carcinomas.
Authors
Amin Nassar
Brigham and Women's Hospital, Boston, MA
Amin Nassar , Renato Umeton , Kevin Lundgren , Lauren Christine Harshman , Eliezer Mendel Van Allen , Toni K. Choueiri , Graeme Steele , Joaquim Bellmunt , Kent William Mouw , Guru Sonpavde , David J. Kwiatkowski
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4527)
DOI
10.1200/JCO.2018.36.15_suppl.4527
Abstract #
4527
Poster Bd #
353
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Genomic alterations in upper tract urothelial carcinoma (UTUC) versus urothelial carcinoma of the bladder (UBC).
First Author: Stephanie A. Mullane
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2023 ASCO Genitourinary Cancers Symposium
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
First Author: Tanya Jindal
Poster
2022 ASCO Genitourinary Cancers Symposium
Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or metastatic urothelial carcinoma.
First Author: Nishita Tripathi